Q2 2024 Holdings
Filed 2024-08-14 | 38 holdings | $164.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| ELI Lilly & Co(LLY) | COM | 532457108 | $24.6M | 27,144 | 15.0% |
| UFP Technologies Inc(UNH) | COM | 91324P102 | $16.1M | 31,680 | 9.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $14.0M | 112,734 | 8.5% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $10.8M | 19,458 | 6.6% |
| Amgen Inc(AMGN) | COM | 031162100 | $8.6M | 27,589 | 5.3% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $8.2M | 106,557 | 5.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $7.2M | 6,893 | 4.4% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $7.1M | 15,095 | 4.3% |
| Cencora Inc(COR) | COM | 03073E105 | $6.8M | 30,320 | 4.2% |
| Stryker Corporation(SYK) | COM | 863667101 | $6.8M | 19,983 | 4.1% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $6.1M | 35,618 | 3.7% |
| Dexcom Inc(DXCM) | COM | 252131107 | $3.9M | 34,483 | 2.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $3.4M | 36,505 | 2.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.3M | 23,630 | 2.0% |
| Iqvia Hldgs Inc(IQV) | COM | 46266C105 | $3.0M | 13,984 | 1.8% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $2.8M | 9,500 | 1.7% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $2.7M | 27,500 | 1.6% |
| UFP Technologies Inc(UFPT) | COM | 902673102 | $2.6M | 9,800 | 1.6% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.6M | 75,200 | 1.6% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $2.5M | 35,841 | 1.5% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $1.9M | 40,691 | 1.2% |
| Merus N V | COM | N5749R100 | $1.8M | 30,837 | 1.1% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $1.8M | 39,100 | 1.1% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $1.7M | 68,800 | 1.0% |
| Option Care Health Inc(OPCH) | COM NEW | 68404L201 | $1.5M | 54,395 | 0.9% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $1.5M | 148,207 | 0.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $1.5M | 75,794 | 0.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $1.4M | 7,624 | 0.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.4M | 53,432 | 0.8% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $1.2M | 22,496 | 0.8% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $1.1M | 34,900 | 0.6% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $805.8K | 23,778 | 0.5% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $787.0K | 226,145 | 0.5% |
| Morphic Hldg Inc | COM | 61775R105 | $688.2K | 20,199 | 0.4% |
| Pharvaris N V(PHVS) | COM | N69605108 | $645.4K | 34,328 | 0.4% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $609.5K | 143,407 | 0.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $481.1K | 64,321 | 0.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $371.6K | 184,900 | 0.2% |